Stock Events

Stock Events

Haemonetics 

$102.92
38
+$0.07+0.07% Friday 20:00
-$0.39-0.38%Friday 23:46After hours

Statistics

Day High
102.98
Day Low
102.79
52W High
109.57
52W Low
47.32
Volume
28,543
Avg. Volume
-
Mkt Cap
4.68B
P/E Ratio
37.17
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
1.01
1.11
1.21
1.31
Expected EPS
1.289717
Actual EPS
N/A

Financials

7.29%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
1.33BRevenue
97.31MNet Income

Analyst Ratings

102.50Average Price Target
The highest estimate is 125.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy
75%
Hold
25%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HAE. It's not an investment recommendation.
Realty Income
9
O
Microsoft
8
MSFT
Amazon
8
AMZN
Coca-Cola
8
KO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Baxter International
BAX
Mkt Cap13.51B
Baxter International Inc. offers a range of products in blood and plasma collection, a direct competition to Haemonetics' blood processing systems.
Becton Dickinson
BDX
Mkt Cap51.62B
Becton, Dickinson and Company provides a variety of medical devices and supplies, including blood collection and management solutions, competing in similar markets as Haemonetics.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific Inc. supplies a wide range of laboratory equipment and consumables, including those for blood and plasma collection and analysis, overlapping with Haemonetics' offerings.
Danaher
DHR
Mkt Cap151.89B
Danaher Corporation's life sciences and diagnostics segments offer products and solutions that compete with Haemonetics in the blood management and diagnostics market.
Mettler-Toledo International
MTD
Mkt Cap28.02B
Mettler-Toledo International Inc. competes in the precision instruments sector, including laboratory equipment and diagnostics that can be used in blood analysis, indirectly competing with Haemonetics.
Resmed
RMD
Mkt Cap34.67B
ResMed Inc. is more focused on sleep and respiratory care, but its expansion into healthcare solutions and monitoring technologies presents a competitive edge in the broader healthcare market against Haemonetics.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation, while primarily focused on medical devices for interventional medical specialties, competes in the healthcare market where Haemonetics also operates, especially in patient care and treatment technologies.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation, known for medical devices and equipment, competes in the healthcare market, offering products that can be used in surgeries and medical treatments where blood management is crucial.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories offers a broad range of healthcare products, including diagnostics and medical devices that compete with Haemonetics in the healthcare and diagnostics market.
Johnson & Johnson
JNJ
Mkt Cap645.95B

About

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
Show more...
CEO
Christopher A. Simon
Employees
3009
Country
United States
ISIN
US4050241003
WKN
000881782

Listings

F
DE
HAZ.F
STU
DE
HAZ.STU
MU
DE
HAZ.MU
XNYS
US
HAE

0 Comments

Share your thoughts

FAQ

What is Haemonetics stock price today?▼
The current price of HAE is $102.92 USD — it has increased by +0.07% in the past 24 hours. Watch Haemonetics stock price performance more closely on the chart.
What is Haemonetics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Haemonetics stocks are traded under the ticker HAE.
Is Haemonetics stock price growing?▼
HAE stock has fallen by -1% compared to the previous week, the month change is a +23.11% rise, over the last year Haemonetics has showed a +89.26% increase.
What is Haemonetics market cap?▼
Today Haemonetics has the market capitalization of 4.68B
When is the next Haemonetics earnings date?▼
Haemonetics is going to release the next earnings report on November 05, 2026.
What were Haemonetics earnings last quarter?▼
HAE earnings for the last quarter are 1.14 USD per share, whereas the estimation was 1.08 USD resulting in a +5.87% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Haemonetics revenue for the last year?▼
Haemonetics revenue for the last year amounts to 1.33B USD.
What is Haemonetics net income for the last year?▼
HAE net income for the last year is 97.31M USD.
How many employees does Haemonetics have?▼
As of September 05, 2026, the company has 3,009 employees.
In which sector is Haemonetics located?▼
Haemonetics operates in the Health & Wellness sector.
When did Haemonetics complete a stock split?▼
The last stock split for Haemonetics was on December 03, 2012 with a ratio of 2:1.
Where is Haemonetics headquartered?▼
Haemonetics is headquartered in BOSTON, United States.